Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Photodynamic Therapy vs Topical Corticosteroid in Oral Lichen Planus
NCT04976673Phase 2Completed
- Sponsor
- Wroclaw Medical University
- Start
- Dec 2020
- Primary completion
- Jan 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of triamcinolone acetonide in oral lichen planus (OLP) (2 arms), sponsored by Wroclaw Medical University. Primary endpoint: Size of Oral lichen planus at 12 weeks. Started Dec 2020; status: completed.
02
Drugs
triamcinolone acetonide
03
Conditions
oral lichen planus (OLP)
Beyond the preview
Go deeper on NCT04976673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04976673.